With many in the field of allergy and immunology focusing attention during the COVID-19 pandemic on how patients with allergies and asthma may be affected if they become infected with the virus, researchers examined hospital data to determine whether patients with allergic conditions experience more severe COVID-19-related outcomes than those without such conditions. “We examined the charts of 275 patients admitted to the hospital who tested positive for the SARS-CoV-2 virus for any history of allergic disease,” Dylan Timberlake, MD, lead author of the study, said in a press release. “Over the 2-month period when we examined the charts, we found the severity of disease didn’t seem to differ between COVID-19 patients with allergies, versus COVID-19 patients without allergies.” Disease severity was determined by such factors as ICU admission, length of stay, need for supplemental oxygen, and intubation rate. Although more patients with allergies had COPD (39% vs 17%)—a known risk factor for severe COVID-19 outcomes—the study team found a statistical trend suggesting possible protection in patients with pre-existing allergic disease, but not asthma, after controlling for the presence of COPD and its association with more severe COVID-related illness.
November 17, 2020
Kidney Week 2020: Intervention Bundle Doesn’t Reduce Hemodialysis Catheter-Related Bloodstream Infection
October 26, 2020
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.
- ENDO: 2020ENDO 2020 Annual Conference has been canceled due to COVID-19. Here are highlights of emerging data that has still been released. Keep an eye out for ENDO Online 2020, which will take place from June 8 to 22.
- CROI 2020Every year, CROI hosts some of the world's leading experts in HIV research, who come to present exciting new data and drive forward the field of HIV/AIDS research. This year, due to COVID-19, CROI held their meeting virtually.